Related Experiment Videos
Microbubble elimination during priming improves biocompatibility of membrane oxygenators
The American Journal of Physiology
|May 1, 1978
Summary
This study shows that removing gas nuclei from medical device surfaces reduces platelet loss and blood clot formation during extracorporeal membrane oxygenation (ECMO). Vacuum priming effectively minimizes blood-material interactions.
Area of Science:
- Biomaterials Science
- Hematology
- Medical Device Engineering
Background:
- Blood contact with foreign materials, such as those in extracorporeal membrane oxygenators (ECMO), can lead to platelet loss and thrombus formation.
- Microbubbles of gas (gas nuclei) trapped in surface defects are hypothesized to contribute to these adverse blood-material interactions.
Purpose of the Study:
- To test the hypothesis that gas nuclei in surface defects contribute to platelet loss during ECMO.
- To evaluate the efficacy of a novel vacuum priming technique designed to eliminate gas nuclei from oxygenator surfaces.
Main Methods:
- Extracorporeal membrane oxygenator perfusions were performed in sheep using two priming techniques: standard priming and a new vacuum priming technique.
- The vacuum priming technique aimed to denucleate the oxygenator surface by removing trapped gas nuclei.
- Platelet loss, thrombus formation, and platelet particle-size distribution were analyzed.
Main Results:
- Vacuum priming significantly reduced platelet loss during perfusion compared to standard priming.
- Thrombus formation on the membrane surface was markedly decreased with the vacuum priming technique.
- Platelet aggregation, indicated by shifts in particle-size distribution, occurred with standard priming but not with vacuum priming.
Conclusions:
- Eliminating trapped gas nuclei from the membrane surface during priming reduces initial blood-material interactions.
- Vacuum priming is an effective method to mitigate platelet loss and thrombus formation in ECMO circuits.
- This technique has implications for improving the biocompatibility of blood-contacting medical devices.